Wakunaga of America Researches a Garlic-Derived Compound
References: news-medical.net
Wakunaga of America has announced that a specific compound found in Kyolic Aged Garlic Extract — known as S-1-propenyl-L-cysteine or S1PC — demonstrated in a peer-reviewed study the ability to counteract skeletal muscle aging by activating an inter-organ communication pathway that connects fat tissue to the brain, which then enhances signalling to muscles.
Published in Cell Metabolism, the research showed that long-term S1PC treatments in aged mice produced significantly increased skeletal muscle force, restored body temperatures to youthful levels, and reduced overall frailty index scores. A randomized double-blind clinical trial in healthy middle-aged humans found that a single oral dose of S1PC-enriched garlic powder successfully increased circulating levels of the key enzyme eNAMPT in subjects with healthy body fat mass.
Wakunaga of America is a company with a decades-long history of researching medicinal herbs.
Image Credit: Wakunaga of America
Published in Cell Metabolism, the research showed that long-term S1PC treatments in aged mice produced significantly increased skeletal muscle force, restored body temperatures to youthful levels, and reduced overall frailty index scores. A randomized double-blind clinical trial in healthy middle-aged humans found that a single oral dose of S1PC-enriched garlic powder successfully increased circulating levels of the key enzyme eNAMPT in subjects with healthy body fat mass.
Wakunaga of America is a company with a decades-long history of researching medicinal herbs.
Image Credit: Wakunaga of America
Trend Themes
-
Garlic-derived Bioactives — Discovery of S1PC highlights small-molecule organosulfur compounds as a new class of bioactives that could redefine natural-product pipelines for muscle-support therapeutics.
-
Inter-organ Signaling Therapeutics — Research linking adipose-to-brain-to-muscle communication reveals signaling pathways as therapeutic targets that could enable drugs or biologics to systemically reverse age-related muscle decline.
-
Nutraceuticals for Sarcopenia — Clinical evidence of an oral garlic-derived ingredient increasing eNAMPT levels suggests evidence-backed nutraceuticals may compete with conventional interventions for preserving muscle function in aging populations.
Industry Implications
-
Pharmaceuticals — Translating S1PC mechanisms into synthetic analogs or repurposed drugs presents opportunities for new prescription treatments addressing frailty and sarcopenia.
-
Nutraceuticals and Supplements — Companies producing standardized, clinically validated garlic formulations could disrupt supplement markets by offering measurable biomarker-responsive products for middle-aged and elderly consumers.
-
Functional Food Manufacturing — Incorporation of S1PC-enriched ingredients into fortified foods offers possibilities for mainstream dietary products that deliver clinically relevant muscle-support benefits.
6.5
Score
Popularity
Activity
Freshness
